Compare · 2 funds side by side · dividends reinvested

IXJ and JDOC

IXJiShares×JDOCJ.P. Morgan×

Versus in desk

02 / 04

−0.1%

IWD+0.2%

Search ETFs and stocks

Portfolio

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$14,077IXJ · best of the two

Story of the two · IncomeMost incomeIXJ · 1.26% · $126 a year on $10k

Story of the two · RiskSmallest drop

IXJ and JDOC, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Global Healthcare ETFSectors · Health care0.38%1.26%+18.9%+20.9%+13.7%+7.1%−10.8%16.2%$4.7B1.3

JPMorgan Healthcare Leaders ETFSectors · Health care0.65%0.76%+16.2%+18.3%+13.2%[…]−9.7%15.7%$10M1.7

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 13, 2026 · returns include dividends · since: IXJ 2001 · JDOC 2023

Head to Head

Swap sides Versus in desk

Head to Head

5Y

iShares Global Healthcare ETF · $4.7B$14,077

IXJ

JDOC

JPMorgan Healthcare Leaders ETF · $10M[…]

$10,000 five years ago, dividends reinvested · they hold 56.3% in common

IXJMeasureJDOC

+18.9%

More Ways to See the Pairs

IXJ vs JDOC: Top 5 Holdings

Today

IXJ

31.6%in top 5

JDOC

in top 531.5%

IXJStockJDOC

11.5%LLY8.7%

5.2%ABBV8.4%

6.8%JNJ4.7%

4.0%UNH5.2%

not top 5NOVN.SW

Cost, Income and Risk

Fees: IXJ, JDOC

Today

0.38%lowest, IXJ

FundExpense ratioFee$10k

IXJ0.38%$38

JDOC0.65%$65

End-of-day Nov 13, 2026 · fee on $10,000 a year

Yields: IXJ, JDOC

1Y

1.26%highest, IXJ

FundTrailing yieldYield

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+34.9%

VIGVanguard

+16.0%

+34.9%Year to date+16.0%

2.9%Yield1.4%

$124BAssets$109B

2–0SCHD wins

End-of-day Nov 13, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.7%

JEPIJ.P. Morgan

+8.2%

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

Year to dateJan 1 → Nov 13

+16.2%

+20.9%1 yearTotal return+18.3%

+13.7%3 years · per year$10,000 became $14,690 · $14,497+13.2%

+7.1%5 years · per year$10,000 became $14,077 · […][…]

0.38%Expense ratio$38 · $65 a year on $10k · lower is better0.65%

1.26%Trailing 12-mo yield$126 · $76 a year on $10k0.76%

−10.8%Worst dropSmaller is better−9.7%

16.2%VolatilityLower is calmer15.7%

IXJJDOC Winner of the row, in its colourEach row: the bigger of the two fills its side

5–2IXJ wins

End-of-day Nov 13, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

4.5%

4.0%MRKnot top 5

Held in common56.3%

End-of-day Nov 13, 2026 · share of each fund

IXJ vs JDOC Returns, Every Period

1Y

iSharesIXJ

+20.9%

past year

JDOCJ.P. Morgan

+18.3%

past year

IXJJDOCFaded: behind in that period

3–0IXJ wins

End-of-day Nov 13, 2026 · dividends in · faded = behind in that period

IXJ vs JDOC

YTD

iSharesIXJ

+18.9%

JDOCJ.P. Morgan

+16.2%

+18.9%Year to date+16.2%

−10.8%Worst drop · 1Y−9.7%

16.2%Volatility · 1Y15.7%

1.3%Yield0.8%

$4.7BAssets$10.1M

2–2level

End-of-day Nov 13, 2026 · smaller drop and lower volatility win

$10k

IXJ1.26%$126

JDOC0.76%$76

End-of-day Nov 13, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$88most kept, IXJ

IXJ$126 − $38 = $88

JDOC$76 − $65 = $11

KeptFee

End-of-day Nov 13, 2026 · yield in dollars minus the fee

Overlap: IXJ, JDOC

Today

56.3%most shared, IXJ and JDOC

IXJJDOC

IXJ—56.3%

JDOC56.3%—

End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+20.9%IXJ, at 16.2% volatility

JDOCWorst drop−9.7%15.7% vol

IXJWorst drop−10.8%16.2% vol

End-of-day Nov 13, 2026 · up and left is better

Paid More vs Made More

YTD

IXJJDOC

+18.9%Year to date+16.2%

1.3%Yield0.8%

+20.9%Past year+18.3%

0.38%Fee0.65%

4–0IXJ wins

End-of-day Nov 13, 2026

+6.7%Year to date+8.2%

12.4%Yield7.9%

$42.6BAssets$47.3B

1–1level

End-of-day Nov 13, 2026

Year to date

+11.5%

1.0%Yield1.0%

$186BAssets$806B

0–0level

End-of-day Nov 13, 2026

Loading…

IXJ and JDOC

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two